BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 7, 2018
View Archived Issues
CARB-X commits financing to support MicuRx's development of polymyxin antibiotic MRX-8
Read More
FDA approves Moleac's IND application for MLC-1501 post-stroke recovery program
Read More
FDA allows IND application for ND-L02-s0201 for idiopathic pulmonary fibrosis to proceed
Read More
miR-511-3p shown to modulate allergic inflammation through CCL2
Read More
FDA accepts NDA for prucalopride for chronic idiopathic constipation
Read More
EMA accepts regulatory submission for Forxiga in adults with type 1 diabetes
Read More
New Eli Lilly GPR40 agonist LY-3104607 shows glucose-lowering potential
Read More
Takeda applies for approval of relugolix for uterine fibrosis in Japan
Read More
Bristol-Myers Squibb sBLA update approved by FDA for Opdivo
Read More
PMN-310 shows similar blood-brain barrier penetration as aducanumab
Read More
European Commission approves Ameluz with daylight PDT
Read More
FDA grants orphan drug designation to PTG-300 for beta-thalassemia
Read More
Celgene completes Juno Therapeutics acquisition
Read More
FDA approves Latuda for treatment of bipolar depression in pediatric patients
Read More
Bavarian Nordic describes phase II results for universal respiratory syncytial virus vaccine
Read More
First patient enrolled in TOPAZ trial of suprachoroidal CLS-TA in retinal vein occlusion
Read More
Themis and CEPI partner on vaccines for Lassa fever and MERS
Read More
Targeting P2Y6 receptor modulates allergic lung inflammation
Read More
FDA grants allowance of IND for FCX-013 gene therapy for scleroderma
Read More
Enrollment completed in phase III study of S-588410 for esophageal cancer
Read More
FDA approves Trogarzo for multidrug-resistant HIV-1
Read More
Ligand grants Roivant rights to glucagon receptor antagonist LGD-6972
Read More
Apexigen and the Pediatric Brain Tumor Consortium collaborate on trial of APX-005M
Read More
Hetero Labs discovers novel betulinic acid analogues
Read More
Splunc1-knockout mice found more susceptible to HDM-induced inflammation
Read More
Novel MAP4K2/ACK-1 kinase inhibitors identified at KIST
Read More
Rigel Pharmaceuticals patents novel AMPK activators
Read More
Vidac Pharma identifies new anticancer piperazine derivatives
Read More
Allena initiates phase III trial of ALLN-177 in patients with enteric hyperoxaluria
Read More
Anti-heroin vaccine demonstrates efficacy in rodents
Read More